240 related articles for article (PubMed ID: 18213649)
1. Use of prothrombin complex concentrates in anticoagulation.
van Veen SQ; Strengers PF
Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
[No Abstract] [Full Text] [Related]
2. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
Quinlan DJ; Eikelboom JW; Weitz JI
Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
[No Abstract] [Full Text] [Related]
3. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
Lang E
Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
[No Abstract] [Full Text] [Related]
4. Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
Dickneite G
Clin Lab Med; 2014 Sep; 34(3):623-35. PubMed ID: 25168947
[TBL] [Abstract][Full Text] [Related]
5. [CORRECTION OF HEMOSTASIS WITH BLOOD PRODUCTS IN THE SURGICAL TREATMENT OF CONGENITAL HEART DISEASE IN INFANTS AND YOUNG CHILDREN].
Rybka MM; Samsonova NN; Klimovich LG; Rogalskaya EA; Khichagov DY; Tataryan FE
Anesteziol Reanimatol; 2015; 60(5):42-6. PubMed ID: 26852579
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
[TBL] [Abstract][Full Text] [Related]
7. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
Schwebach AA; Waybright RA; Johnson TJ
Pharmacotherapy; 2019 May; 39(5):599-608. PubMed ID: 30892733
[TBL] [Abstract][Full Text] [Related]
8. Human prothrombin complex.
N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
[No Abstract] [Full Text] [Related]
9. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
Fischer M
Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
[TBL] [Abstract][Full Text] [Related]
10. [Administration of a new prothrombin complex concentrate in patients treated with anticoagulants and in patients with liver diseases].
Fischer M; Falkensammer C; Gauss P; Korp W; Kubiena K; Neubert J; Schnack H; Weissmann A
Med Welt; 1973 Nov; 24(48):1899-902. PubMed ID: 4774863
[No Abstract] [Full Text] [Related]
11. Prothrombin complex concentrates: clinical use.
Menache D
Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
[No Abstract] [Full Text] [Related]
12. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?
Makris M
J Thromb Haemost; 2014 Sep; 12(9):1425-7. PubMed ID: 25039898
[No Abstract] [Full Text] [Related]
14. Use of four-factor prothrombin complex concentrate in the emergency department: a review.
Willis CM; Hall AB
J Emerg Nurs; 2015 Jan; 41(1):9-12. PubMed ID: 25016517
[No Abstract] [Full Text] [Related]
15. [On the problem of enteral resorption of coagulation factors in early infancy].
Göltner E; Ströder J
Wien Klin Wochenschr; 1966 Oct; 78(41):695-7. PubMed ID: 5929473
[No Abstract] [Full Text] [Related]
16. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
O'Leary DS; Ruymann FB; Conrad ME
J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
[No Abstract] [Full Text] [Related]
17. New concentrates of factors VII, IX and X.
Menache D
Prog Clin Biol Res; 1990; 324():177-87. PubMed ID: 2408052
[No Abstract] [Full Text] [Related]
18. Recent advances in the control of anticoagulant therapy.
Owren PA
Geriatrics; 1971 Aug; 26(8):74 passim. PubMed ID: 5096463
[No Abstract] [Full Text] [Related]
19. Emergent reversal of vitamin K antagonists: addressing all the factors.
Martin DT; Barton CA; Dodgion C; Schreiber M
Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
